Results 31 to 40 of about 8,460,931 (324)

Clinicopathological Correlates of Lewy Body Disease: Fundamental Issues [PDF]

open access: yesJournal of Movement Disorders, 2010
Lewy body pathology (LBP) is the pathological hallmark of Lewy body diseases, such as Parkinson’s disease and Lewy body dementia. Recent studies have shed new light on the role of LBP, the interactions of LBP with concomitant pathologies, and the ...
Tae-Beom Ahn
doaj   +1 more source

Evaluating a young-onset dementia service from two sides of the coin: staff and service user perspectives

open access: yesBMC Health Services Research, 2020
Background People with young-onset dementia (YOD) can often struggle getting the right treatment. This is because of their frequently different characteristics and needs compared to people with late-onset dementia. The aim of this project was to assess a
Clarissa Giebel   +5 more
doaj   +1 more source

Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium

open access: yesFrontiers in Neurology, 2022
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and ...
Gregory D. Scott   +54 more
doaj   +1 more source

End of life care in UK care homes during the COVID-19 pandemic: a qualitative study

open access: yesBMC Palliative Care, 2022
Purpose To report the experiences of End of Life (EoL) care in UK care homes during the COVID-19 pandemic. Methods UK care home staff and family carers of residents in care home took part in remote, semi-structured interviews from October to November ...
Kerry Hanna   +8 more
doaj   +1 more source

RT‐QuIC Detection of Pathological α‐Synuclein in Skin Punches of Patients with Lewy Body Disease

open access: yesMovement Disorders, 2021
Evidence suggests that skin represents a suitable matrix for demonstrating α‐synuclein oligomers as a diagnostic biomarker for Lewy body disease.
A. Mammana   +7 more
semanticscholar   +1 more source

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions [PDF]

open access: yesJournal of Movement Disorders, 2020
The aim of this article is to describe the 2017 revised consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic criteria.
Masahito Yamada   +6 more
doaj   +1 more source

Dementia with Lewy bodies [PDF]

open access: yesClinical Medicine, 2019
Editor – Akintade and Pierres provide a useful review of the evaluation of cognitive impairment in their Acute Medical Care (AMC) report in July’s Clinical Medicine .[1][1] However, the patient described in their report does not have dementia with Lewy bodies (DLB).
openaire   +5 more sources

Improving the diagnosis and management of Lewy body dementia: the DIAMOND-Lewy research programme including pilot cluster RCT

open access: yesProgramme Grants for Applied Research, 2021
Background: Lewy body dementia, comprising both dementia with Lewy bodies and Parkinson’s disease dementia, is the second commonest cause of neurodegenerative dementia.
John T O’Brien   +17 more
doaj   +1 more source

Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings

open access: yesAlzheimer’s Research & Therapy, 2019
The first Lewy Body Dementia Association (LBDA) Research Centers of Excellence (RCOE) Investigator’s meeting was held on December 14, 2017, in New Orleans.
Bethany Peterson   +44 more
doaj   +1 more source

Neuropathology and molecular diagnosis of Synucleinopathies

open access: yesMolecular Neurodegeneration, 2021
Synucleinopathies are clinically and pathologically heterogeneous disorders characterized by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies, Lewy neurites, neuronal cytoplasmic inclusions, and glial cytoplasmic ...
Shunsuke Koga   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy